"339177-26-3" . "6A901E312A" . "L01" . "Panitumumab (INN), formerly ABX-EGF, is a fully human monoclonal antibody specific to the epidermal growth factor receptor (also known as EGF receptor, EGFR, ErbB-1 and HER1 in humans).Panitumumab is manufactured by Amgen and marketed as Vectibix. It was originally developed by Abgenix Inc.In 2014, Amgen and Illumina entered into an agreement to develop a companion diagnostic to accompany panitumumab."@en . "XC08" . "DB01269" .